EPCAM and cancer: The CELLSEARCH® System is the first case that has been approved for clinical use by the Food and Drug Administration (FDA) and enables the detection and follow-up of cancer cells in the blood by observing the expression of epithelial cell adhesion molecule (EpCAM) and cytokeratin, which are known as representative cancer cell-specific molecular targets [17].